Guangdong Shuanglin Bio-Pharmaceutical

Guangdong Shuanglin Bio-Pharmaceutical is a prominent Chinese biopharmaceutical company specializing in the research, development, and large-scale production of blood products. As a core subsidiary of the publicly traded Pailin Bio, the company operates a comprehensive network of plasma collection centers and a state-of-the-art manufacturing base in Zhanjiang. Its commercial portfolio includes essential plasma-derived therapies such as human albumin, intravenous immunoglobulin (IVIG), and various specific immunoglobulins and coagulation factors. The company is a key player in China's plasma-derived medicinal products (PDMP) market, focusing on high-quality biologics for critical care, immunology, and hematology. Recent strategic reorganizations have strengthened its position as one of the largest plasma fractionation entities in the country.